Cieślicka T
Pol Med Sci Hist Bull (1973). 1976 Apr-Jun;15(2):235-9.
Total hydroxyproline excretion in 24-hour urine was determined in 20 cases of systemic lupus erythematosus (SLE) before and during treatment. Additionally the excretion of hydroxyproline was determined in 14 patients receiving steroids for various other diseases (endocarditis, thrombocytopenia, acute leukemia, apofocal polyarthritis, ischialgia, spastic bronchitis, pleuritis and Dressler's post-infarction syndrome). The normal hydroxyproline value was established in 40 healthy persons. The normalization of pathologically increased hydroxyproline excretion in patients with SLE during treatment with prednisone in doses from 1.0 to 1.35 mg/kg/daily was associated with remission of clinical symptoms. Large doses of prednisone in pathological processes not primarily affecting connective tissue increased the 24-hour excretion of hydroxyproline and small doses of prednisone had no effect on hydroxyprolinuria.
测定了20例系统性红斑狼疮(SLE)患者治疗前及治疗期间24小时尿中总羟脯氨酸排泄量。此外,还测定了14例因各种其他疾病(心内膜炎、血小板减少症、急性白血病、局灶性多关节炎、坐骨神经痛、痉挛性支气管炎、胸膜炎和德雷斯勒梗死后综合征)接受类固醇治疗的患者的羟脯氨酸排泄量。在40名健康人中确定了正常的羟脯氨酸值。SLE患者在接受剂量为1.0至1.35mg/kg/日的泼尼松治疗期间,病理增加的羟脯氨酸排泄量恢复正常与临床症状缓解相关。在并非主要影响结缔组织的病理过程中,大剂量泼尼松会增加24小时羟脯氨酸排泄量,而小剂量泼尼松对羟脯氨酸尿症无影响。